Full text is available at the source.
Abstract
Obesity is linked to at least 13 types of cancer.
- Glucagon-like peptide-1 receptor agonists (GLP-1RAs) may lead to significant weight loss.
- GLP-1RAs are associated with improvements in metabolic and inflammatory processes that could influence cancer development.
- There is emerging evidence from various study types, including preclinical and randomized trials, connecting GLP-1RAs to obesity-related cancer incidence and outcomes.
Simplified